BrainsWay (TLV:BWAY) Full Year 2024 Results
Key Financial Results
- Revenue: US$41.0m (up 29% from FY 2023).
- Net income: US$2.92m (up from US$4.20m loss in FY 2023).
- Profit margin: 7.1% (up from net loss in FY 2023). The move to profitability was driven by higher revenue.
- EPS: US$0.086 (up from US$0.13 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
BrainsWay Earnings Insights
The primary driver behind last 12 months revenue was the U.S. segment contributing a total revenue of US$33.2m (81% of total revenue). The largest operating expense was Sales & Marketing costs, amounting to US$16.2m (56% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of US$1.53m. Explore how BWAY's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Medical Equipment industry in Asia.
Performance of the market in Israel.
The company's shares are up 3.5% from a week ago.
Balance Sheet Analysis
While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on BrainsWay's balance sheet.
Valuation is complex, but we're here to simplify it.
Discover if BrainsWay might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.